Formats
  1. Journal Article (66987)
  2. Meeting Abstract (33621)
  3. Book Section (5116)
  4. Review (3796)
  5. Editorial (2199)
  6. Conference Paper (1527)
  7. Correspondence (670)
  8. Guidelines (668)
  9. Research Letter (555)
  10. Book Whole (345)
  11. Miscellaneous (340)
Groups
  1. Department of Medicine (39140)
  2. GSK Faculty (22507)
  3. Solid Tumor Oncology Division (22124)
  4. Surgery (21323)
  5. Survivorship Research (15803)
  6. Sloan Kettering Institute Faculty (15667)

More Groups

People
  1. Marc Ladanyi (1329)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1053)

More People

Years
  1. 2026 (1)
  2. 2025 (2355)
  3. 2024 (5382)
  4. 2023 (5808)
  5. 2022 (6169)
  6. 2021 (5721)

More Years

Publications
  1. Journal of Clinical Oncology (8596)
  2. Blood (4954)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2615)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13871)
  2. American Society of Clinical Oncology (9181)
  3. Springer (7204)
  4. Nature Publishing Group (6393)
  5. American Association for Cancer Research (6016)
  6. Elsevier Science, Inc. (5529)

More Publishers

Results (115824)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of nintedanib in recurrent malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Wozniak, A. J.; Schneider, B. J.; Kalemkerian, G. P.; Daly, R. M.; Chen, W.; Ventimiglia, J.; Nagasaka, M.; Zauderer, M. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase I study of OKT3 x hu3F8 bispecific antibody (GD2Bi) armed T cells (GD2BATs) in GD2-positive tumors
    Meeting Abstract

    Yankelevich, M.; Modak, S.; Chu, R.; Lee, D. W.; Thakur, A.; Cheung, N. K. V.; Lum, L. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical outcomes and cost-effectiveness of breast cancer screening for childhood cancer survivors treated with chest radiation: A comparative modeling study
    Meeting Abstract

    Yeh, J.; Lowry, K. P.; Schechter, C. B.; Diller, L.; Alagoz, O.; Armstrong, G. T.; Hampton, J. M.; Leisenring, W.; Liu, Q.; Mandelblatt, J. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Multiparametric magnetic resonance imaging (mpMRl) and PSA density for the prediction of reclassification among patients under active surveillance
    Meeting Abstract

    Viana, P.; Horvat, N.; Pessoa, R. R.; Horvat, J.; Park, R.; Guglielmetti, G.; Bastos, D. A.; Cordeiro, M.; Coelho, R.; Vargas, H. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • ABI-009 (nab-sirolimus) in advanced malignant perivascular epithelioid cell tumors (PEComa): Preliminary efficacy, safety, and mutational status from AMPECT, an open label phase II registration trial
    Meeting Abstract

    Wagner, A. J.; Ravi, V.; Ganjoo, K. N.; Van Tine, B. A.; Riedel, R. F.; Chugh, R.; Cranmer, L. D.; Gordon, E. M.; Hornick, J. L.; Kwiatkowski, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) cancer: Long-term follow up from KEYNOTE-059
    Meeting Abstract

    Wainberg, Z. A.; Yoon, H. H.; Catenacci, D. V. T.; Jalal, S. I.; Muro, K.; Garrido, M.; Golan, T.; Doi, T.; Geva, R.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Safety and preliminary efficacy in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) receiving lisocabtagene maraleucel (Liso-cel) in TRANSCEND NHL 001
    Meeting Abstract

    Wang, M.; Gordon, L. I.; Palomba, M. L.; Abramson, J. S.; Andreadis, C.; Ghosh, N.; Lunning, M. A.; Maloney, D. G.; Farazi, T. A.; Garcia, J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in pediatric TRK fusion cancer patients
    Meeting Abstract

    van Tilburg, C. M.; DuBois, S. G.; Albert, C. M.; Federman, N.; Nagasubramanian, R.; Geoerger, B.; Orbach, D.; Bielack, S. S.; Shukla, N. N.; Turpin, B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Modeling accrual of older adults to cancer clinical trials: (Alliance A151736)
    Meeting Abstract

    VanderWalde, N. A.; Wakefield, D. V.; Satele, D. V.; Dockter, T.; Sloan, J. A.; Jagsi, R.; Lichtman, S. M.; Freedman, R. A.; Lafky, J. M.; Muss, H. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Non-invasive detection of acquired resistance to FGFR inhibition in patients with cholangiocarcinoma harboring FGFR2 alterations
    Meeting Abstract

    Varghese, A. M.; Patel, J. A. A.; Janjigian, Y. Y.; Meng, F.; Selcuklu, S. D.; Zimel, C.; Hyman, D. M.; Iyer, G.; Houck-Loomis, B.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save